Danaher Co. (NYSE:DHR) announced a quarterly dividend on Tuesday, December 10th, RTT News reports. Shareholders of record on Friday, December 27th will be paid a dividend of 0.17 per share by the conglomerate on Friday, January 31st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.46%.
Shares of NYSE:DHR traded up $1.28 during trading hours on Tuesday, reaching $148.81. The stock had a trading volume of 2,131,080 shares, compared to its average volume of 7,418,995. Danaher has a 1 year low of $94.59 and a 1 year high of $149.61. The firm’s 50 day moving average is $140.74 and its 200-day moving average is $140.16. The company has a debt-to-equity ratio of 0.52, a quick ratio of 3.09 and a current ratio of 3.43. The stock has a market capitalization of $106.46 billion, a price-to-earnings ratio of 32.93, a P/E/G ratio of 2.62 and a beta of 0.92.
Danaher (NYSE:DHR) last announced its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 EPS for the quarter, beating the Zacks’ consensus estimate of $1.15 by $0.01. The company had revenue of $5.04 billion for the quarter, compared to the consensus estimate of $5.02 billion. Danaher had a net margin of 12.13% and a return on equity of 11.42%. The company’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.10 EPS. Analysts forecast that Danaher will post 4.76 EPS for the current year.
A number of research firms recently commented on DHR. Credit Suisse Group reaffirmed an “outperform” rating and issued a $151.00 target price on shares of Danaher in a research report on Monday, October 14th. Needham & Company LLC dropped their target price on shares of Danaher from $155.00 to $152.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. ValuEngine downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Stifel Nicolaus reaffirmed a “hold” rating and issued a $150.00 target price on shares of Danaher in a research report on Thursday, November 14th. Finally, UBS Group increased their target price on shares of Danaher from $158.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, December 2nd. Five investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $147.53.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: What are catch-up contributions?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.